fda import alert green list glp-1 semaglutide tirzepatide 2025 Food and Drug Administration Launches “Green List” for Drug 3 questions to consider: ,
Description
Most people who reach their goal weight and then stop taking the medication just gain the weight back
Semaglutide side effect rates by dose The jump in side effects from 1.0 mg to 2.4 mg is dramatic
Its appetite effect creates a trade-off
They usually get better as your body gets used to the medicine
The FDA has approved these medications for chronic weight management in adults with obesity (body mass index 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or dyslipidemia
[1] Liraglutide isnt suitable for everyone
